In this phase 2 study, researchers aimed to evaluate the effectiveness of tyrosine kinase inhibition in relapsed or refractory germ cell tumors.
Leerink Global Healthcare Conference 2026 March 11, 2026 9:20 AM EDTCompany ParticipantsThierry Pieton - Executive VP ...
DETROIT, March 11, 2026 /PRNewswire/ -- Caracal Products & Services, a leader in the health care solutions, recycling services, and distribution space, has added cutting-edge protective gloves to its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results